These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Nitric oxide (NO): an emerging target for the treatment of glaucoma. Cavet ME; Vittitow JL; Impagnatiello F; Ongini E; Bastia E Invest Ophthalmol Vis Sci; 2014 Aug; 55(8):5005-15. PubMed ID: 25125670 [TBL] [Abstract][Full Text] [Related]
6. A Review of Nitric Oxide for the Treatment of Glaucomatous Disease. Aliancy J; Stamer WD; Wirostko B Ophthalmol Ther; 2017 Dec; 6(2):221-232. PubMed ID: 28584936 [TBL] [Abstract][Full Text] [Related]
7. New considerations for the clinical efficacy of old and new topical glaucoma medications. MacIver S; Stout N; Ricci O Clin Exp Optom; 2021 Apr; 104(3):350-366. PubMed ID: 33725467 [TBL] [Abstract][Full Text] [Related]
8. Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension. Hoy SM Drugs; 2018 May; 78(7):773-780. PubMed ID: 29761382 [TBL] [Abstract][Full Text] [Related]
9. Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension. Fingeret M; Gaddie IB; Bloomenstein M Clin Exp Optom; 2019 Nov; 102(6):541-550. PubMed ID: 30614563 [TBL] [Abstract][Full Text] [Related]
10. The Application of Nitric Oxide for Ocular Hypertension Treatment. Han B; Song M; Li L; Sun X; Lei Y Molecules; 2021 Dec; 26(23):. PubMed ID: 34885889 [TBL] [Abstract][Full Text] [Related]
12. [Influence of prostaglandins on aqueous humour dynamics and intraocular pressure]. Raber T Klin Monbl Augenheilkd; 2005 Oct; 222(10):802-6. PubMed ID: 16240273 [TBL] [Abstract][Full Text] [Related]
13. Management of glaucoma: focus on pharmacological therapy. Marquis RE; Whitson JT Drugs Aging; 2005; 22(1):1-21. PubMed ID: 15663346 [TBL] [Abstract][Full Text] [Related]
14. Trabecular meshwork as a new target for the treatment of glaucoma. Ferrer E Drug News Perspect; 2006 Apr; 19(3):151-8. PubMed ID: 16804567 [TBL] [Abstract][Full Text] [Related]
15. Rho kinase inhibitors for glaucoma treatment - Review. Germano RA; Finzi S; Challa P; Susanna Junior R Arq Bras Oftalmol; 2015; 78(6):388-91. PubMed ID: 26677046 [TBL] [Abstract][Full Text] [Related]
16. Advances in the discovery of novel agents for the treatment of glaucoma. Mincione F; Nocentini A; Supuran CT Expert Opin Drug Discov; 2021 Oct; 16(10):1209-1225. PubMed ID: 33914670 [TBL] [Abstract][Full Text] [Related]
17. Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys. Wang RF; Lee PY; Mittag TW; Podos SM; Serle JB; Becker B Arch Ophthalmol; 1998 Sep; 116(9):1213-6. PubMed ID: 9747682 [TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide in murine conventional outflow physiology. Chang JY; Stamer WD; Bertrand J; Read AT; Marando CM; Ethier CR; Overby DR Am J Physiol Cell Physiol; 2015 Aug; 309(4):C205-14. PubMed ID: 26040898 [TBL] [Abstract][Full Text] [Related]